Published in Biochemistry on March 01, 1994
Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc Natl Acad Sci U S A (1998) 3.31
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis. J Virol (2000) 1.84
Structural basis of HIV-1 resistance to AZT by excision. Nat Struct Mol Biol (2010) 1.50
Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates. Antimicrob Agents Chemother (2000) 1.49
Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J (2000) 1.40
Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (2002) 1.25
ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (2002) 1.23
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription. Antimicrob Agents Chemother (1996) 1.16
AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP. Nucleic Acids Res (2007) 0.95
Resistance to nucleoside analogs of selective mutants of human immunodeficiency virus type 2 reverse transcriptase. J Virol (1995) 0.86
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance. Viruses (2010) 0.85
Ab initio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: implications for nucleoside-analog drug resistance. Protein Sci (2000) 0.77
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12
Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science (1991) 3.18
Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci U S A (2000) 3.13
Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation (1984) 2.71
L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1995) 2.39
Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. Biochemistry (1986) 2.20
Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity. J Biol Chem (1996) 1.94
Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Sci (1998) 1.90
Quantification of atrial contribution to left ventricular filling by pulsed Doppler echocardiography and the effect of age in normal and diseased hearts. Am J Cardiol (1987) 1.87
Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography. Circulation (1985) 1.77
Effect of cysteine-25 on the ionization of histidine-159 in papain as determined by proton nuclear magnetic resonance spectroscopy. Evidence for a his-159--Cys-25 ion pair and its possible role in catalysis. Biochemistry (1981) 1.64
X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform. J Mol Biol (2000) 1.63
Imidazole-catalyzed displacement of an amine from an amide by a neighboring hydroxyl group. A model for the acylation of chymotrypsin. J Am Chem Soc (1971) 1.59
Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. J Biol Chem (1994) 1.51
Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies. Arch Biochem Biophys (1985) 1.48
Predominance of tyrosine phosphorylation of insulin receptors during the initial response of intact cells to insulin. J Biol Chem (1985) 1.45
Physician behavior in Southern Appalachia: some recruitment factors. J Health Soc Behav (1971) 1.45
Ventilatory control during exercise in calves with artificial hearts. J Appl Physiol (1985) (1990) 1.40
Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays. Biochemistry (2000) 1.30
Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials. J Biol Chem (1995) 1.29
Hydrolysis of esters by carboxypeptidase A requires a penta-coordinate metal ion. J Biol Chem (1982) 1.27
Host cell factor requirement for hepatitis C virus enzyme maturation. Proc Natl Acad Sci U S A (2001) 1.27
Catalytic role of the metal ion of carboxypeptidase A in ester hydrolysis. J Biol Chem (1979) 1.27
Nucleoside analog inhibitors of hepatitis C virus replication. Infect Disord Drug Targets (2006) 1.25
Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem (1985) 1.23
Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia (2004) 1.21
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. J Biol Chem (1983) 1.20
Cleavage of oligoribonucleotides by the 2',5'-oligoadenylate- dependent ribonuclease L. J Biol Chem (1996) 1.17
The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. J Biol Chem (1990) 1.15
Active human cytomegalovirus protease is a dimer. J Biol Chem (1996) 1.13
Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol (1986) 1.08
Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: interactive binding between substrates and a preferred kinetic pathway. Biochemistry (1993) 1.08
Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue. J Biol Chem (1981) 1.08
Stoichiometry of 2',5'-oligoadenylate-induced dimerization of ribonuclease L. A sedimentation equilibrium study. J Biol Chem (1996) 1.08
Potentiometric determination of ionizations at the active site of papain. Biochemistry (1976) 1.07
Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates. Biochemistry (1994) 1.07
Solution oligomerization of the rev protein of HIV-1: implications for function. Biochemistry (1993) 1.06
Kinetic pathway for the slow to fast transition of thrombin. Evidence of linked ligand binding at structurally distinct domains. J Biol Chem (1997) 1.06
Activation of RNase L by 2',5'-oligoadenylates. Biophysical characterization. J Biol Chem (1997) 1.04
Non-active site changes elicit broad-based cross-resistance of the HIV-1 protease to inhibitors. J Biol Chem (1999) 1.04
An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. Circulation (1995) 1.03
Kinetic parameters for the binding of p-nitrophenyl alpha-d-mannopyranoside to concanavalin A. Arch Biochem Biophys (1976) 1.02
The right-to-left shunt of crocodilians serves digestion. Physiol Biochem Zool (2008) 1.01
Dependence of the catalytic activity of papain on the ionization of two acidic groups. J Biol Chem (1978) 0.99
Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry (1985) 0.99
Activity and dimerization of human immunodeficiency virus protease as a function of solvent composition and enzyme concentration. J Biol Chem (1992) 0.99
Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes. Biochemistry (1988) 0.98
The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. J Biol Chem (2001) 0.98
Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs. J Biol Chem (1994) 0.97
Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem (1994) 0.96
Zn(II)-induced cooperativity of Escherichia coli ornithine transcarbamoylase. Proc Natl Acad Sci U S A (1982) 0.96
An alternate binding site for the P1-P3 group of a class of potent HIV-1 protease inhibitors as a result of concerted structural change in the 80s loop of the protease. Acta Crystallogr D Biol Crystallogr (2000) 0.95
The DeBakey ventricular assist device: current status in 1997. Artif Organs (1999) 0.94
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence. J Biol Chem (1993) 0.94
In vivo evaluation of a peripheral vascular access axial flow blood pump. ASAIO Trans (1989) 0.94
Purification of active herpes simplex virus-1 protease expressed in Escherichia coli. J Biol Chem (1994) 0.94
Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans. J Biol Chem (1999) 0.94
Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry (1983) 0.94
A two-step procedure for purification of papain from extract of papaya latex. Arch Biochem Biophys (1974) 0.93
Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin. J Biol Chem (1990) 0.93
Heterogeneity in limb fatty acid kinetics in type 2 diabetes. Diabetologia (2005) 0.93
A reagent for covalently attaching biotin to proteins via a cleavable connector arm. Arch Biochem Biophys (1982) 0.92
Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase. J Biol Chem (1989) 0.92
Ionization of a nitrophenol-containing reporter group at the active site of papain. Biochemistry (1974) 0.92
Saving the aortic and pulmonary artery valves with total heart replacement. Trans Am Soc Artif Intern Organs (1976) 0.92
Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. Biochemistry (1992) 0.92
Reactions of pyrzdoxal 5'-phosphate, 6-aminocaproic acid, cysteine, and penicilamine. Models for reactions of Schiff base linkages in pyridoxal 5'-phosphate-requiring enymes. J Biol Chem (1975) 0.91
Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogs. J Biol Chem (1998) 0.91
Reversal of myocardial ischemia by arterialization of the coronary vein. J Thorac Cardiovasc Surg (1974) 0.91
A facile system for construction of HSV-1 variants: site directed mutation of the UL26 protease gene in HSV-1. J Virol Methods (1996) 0.91
Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection. Clin Exp Immunol (2005) 0.91
Relation of Doppler-derived left ventricular filling parameters to age and radius/thickness ratio in normal and pathologic states. Am J Cardiol (1987) 0.90
D-serine dehydratase from Escherichia coli. DNA sequence and identification of catalytically inactive glycine to aspartic acid variants. J Biol Chem (1988) 0.90
Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII. Biochemistry (1987) 0.90
Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide A. Thromb Res (1993) 0.90
Substrate specificity and protonation state of ornithine transcarbamoylase as determined by pH studies. Biochemistry (1985) 0.90
The glycine-rich region of Escherichia coli D-serine dehydratase. Altered interactions with pyridoxal 5'-phosphate produced by substitution of aspartic acid for glycine. J Biol Chem (1988) 0.90
Determination of a low pK for histidine-159 in the S-methylthio derivative of papain by proton nuclear magnetic resonance spectroscopy. Biochemistry (1981) 0.90
Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution. Arch Biochem Biophys (1995) 0.89
Factors influencing the accuracy of the cardiac output monitoring and diagnostic unit for pneumatic artificial hearts. ASAIO Trans (1991) 0.89
Zn2+ regulation of ornithine transcarbamoylase. I. Mechanism of action. J Mol Biol (1990) 0.89
Evidence that insulin receptor from human placenta has a high affinity for only one molecule of insulin. J Biol Chem (1984) 0.89
Carbohydrate binding properties of the stinging nettle (Urtica dioica) rhizome lectin. Arch Biochem Biophys (1986) 0.89
Activation of RNase L by 2',5'-oligoadenylates. Kinetic characterization. J Biol Chem (1997) 0.88
Myocardial mechanics, energetics, and hemodynamics during intraaortic balloon and transvalvular axial flow hemopump support with a bovine model of ischemic cardiac dysfunction. ASAIO J (2000) 0.88
Complications common to ventricular assist device support are rare with 90 days of DeBakey VAD support in calves. ASAIO J (2001) 0.88
A spectrophotometric study of the carbohydrate binding site of concanavalina. J Biol Chem (1974) 0.88
Purification and characterization of HIV-1 reverse transcriptase having a 1:1 ratio of p66 and p51 subunits. Protein Expr Purif (1994) 0.88